So, we speculated that lincSCRG1 probably acts as a pro-fibrotic and pro-tumorigenic regulator to trigger HSCs and CAFs in the pathological progression from liver fibrosis to cirrhosis, and finally carcinogenesis. Here, SCRG1 is linked to Hepatic fibrosis.